Ryoichi Maenosono

9PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

|May 10, 2026
Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.

|Mar 15, 2026
The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

Takeshi Tsutsumi, Shogo Yamazaki, Takuya Matsuda

|Feb 02, 2026
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan.

Keita Kobayashi, Kei Daizumoto, Takuya Tsujino

|Aug 20, 2025
Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study.

Takuhisa Nukaya, Kiyoshi Takahara, Shingo Toyoda

|Aug 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.

Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto

Pageof 2

Frequent Collaborators

4 joint publications

Wataru Fukuokaya

4 joint publications

Takafumi Yanagisawa

3 joint publications

Takuya Tsujino

3 joint publications

Takahiro Kimura